• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阐明 在尿路上皮癌中的表达相关的生物学功能和临床意义。

Elucidating the Associated Biological Function and Clinical Significance of Expression in Urothelial Carcinoma.

机构信息

Department of Biochemistry, National Defense Medical Center, Taipei 114, Taiwan.

Graduate Institute of Life Sciences, National Defense Medical Center, Taipei 114, Taiwan.

出版信息

Int J Mol Sci. 2023 Sep 14;24(18):14081. doi: 10.3390/ijms241814081.

DOI:10.3390/ijms241814081
PMID:37762382
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10531362/
Abstract

Urothelial cancer, a common urinary system malignancy, often presents treatment challenges due to metastasis and chemotherapy side effects. Angiogenesis, crucial for tumor growth, has become a target for drug development. This study explores the expression, prognostic value, and clinical correlation of in the TCGA BLCA, GSE31684, and GSE32894 datasets. We identify common differentially expressed genes across these databases and utilize g:Profiler and Cytoscape ClueGO for functional assessment. Further, we perform a gene set enrichment analysis (GSEA) using Hallmark gene sets and use the imsig package for immune cell infiltration analysis. Our analysis indicates that expression levels significantly impact survival rates, tumor progression, and immune response in urothelial tumors. High expression correlated with poor prognosis, advanced disease stages, and an increase in monocyte population within the tumor microenvironment. This aligns with current literature indicating a key role of immune infiltration in bladder cancer progression and treatment response. Moreover, the GSEA and imsig results further suggest a potential mechanistic link between expression and immune-related pathways. Considering the increasing emphasis on immunotherapeutic strategies in bladder cancer management, our findings on 's potential as a diagnostic biomarker and its association with immune response open new avenues for therapeutic interventions.

摘要

膀胱癌是一种常见的泌尿系统恶性肿瘤,由于转移和化疗副作用,常带来治疗挑战。血管生成对于肿瘤生长至关重要,已成为药物开发的靶点。本研究通过 TCGA BLCA、GSE31684 和 GSE32894 数据集,探讨了 在其中的表达、预后价值和临床相关性。我们确定了这些数据库中常见的差异表达基因,并使用 g:Profiler 和 Cytoscape ClueGO 进行功能评估。此外,我们使用 Hallmark 基因集进行基因集富集分析(GSEA),并使用 imsig 包进行免疫细胞浸润分析。我们的分析表明, 在尿路上皮肿瘤中的表达水平显著影响生存率、肿瘤进展和免疫反应。高 表达与预后不良、疾病进展期和肿瘤微环境中单核细胞群体增加相关。这与当前文献表明免疫浸润在膀胱癌进展和治疗反应中的关键作用一致。此外,GSEA 和 imsig 结果进一步表明 表达与免疫相关途径之间存在潜在的机制联系。鉴于免疫治疗策略在膀胱癌管理中的重要性日益增加,我们关于 '的发现作为一种诊断生物标志物的潜力及其与免疫反应的关联为治疗干预开辟了新途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b86/10531362/dff49de389cd/ijms-24-14081-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b86/10531362/1ac15fc5797c/ijms-24-14081-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b86/10531362/eff692e4b94b/ijms-24-14081-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b86/10531362/c3c379132dd2/ijms-24-14081-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b86/10531362/e033ead350fb/ijms-24-14081-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b86/10531362/ae726f0f9730/ijms-24-14081-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b86/10531362/4795e1d03406/ijms-24-14081-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b86/10531362/ec789c78835d/ijms-24-14081-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b86/10531362/dff49de389cd/ijms-24-14081-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b86/10531362/1ac15fc5797c/ijms-24-14081-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b86/10531362/eff692e4b94b/ijms-24-14081-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b86/10531362/c3c379132dd2/ijms-24-14081-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b86/10531362/e033ead350fb/ijms-24-14081-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b86/10531362/ae726f0f9730/ijms-24-14081-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b86/10531362/4795e1d03406/ijms-24-14081-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b86/10531362/ec789c78835d/ijms-24-14081-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b86/10531362/dff49de389cd/ijms-24-14081-g008.jpg

相似文献

1
Elucidating the Associated Biological Function and Clinical Significance of Expression in Urothelial Carcinoma.阐明 在尿路上皮癌中的表达相关的生物学功能和临床意义。
Int J Mol Sci. 2023 Sep 14;24(18):14081. doi: 10.3390/ijms241814081.
2
Prognostic value of COL10A1 and its correlation with tumor-infiltrating immune cells in urothelial bladder cancer: A comprehensive study based on bioinformatics and clinical analysis validation.COL10A1 在尿路上皮膀胱癌中的预后价值及其与肿瘤浸润免疫细胞的相关性:基于生物信息学和临床分析验证的综合研究。
Front Immunol. 2023 Mar 17;14:955949. doi: 10.3389/fimmu.2023.955949. eCollection 2023.
3
Prognostic significance and immunoinfiltration analysis of genes associated with epithelial-mesenchymal transition and energy metabolism in bladder urothelial carcinoma.与膀胱尿路上皮癌上皮-间质转化和能量代谢相关基因的预后意义及免疫浸润分析。
Aging (Albany NY). 2023 Nov 24;15(22):13312-13328. doi: 10.18632/aging.205242.
4
Uncovering the potential functions of lymph node metastasis-associated aberrant methylation differentially expressed genes and their association with the immune infiltration and prognosis in bladder urothelial carcinoma.揭示淋巴结转移相关异常甲基化差异表达基因的潜在功能及其与膀胱癌免疫浸润和预后的关系。
PeerJ. 2023 Apr 24;11:e15284. doi: 10.7717/peerj.15284. eCollection 2023.
5
PRR11 is a prognostic biomarker and correlates with immune infiltrates in bladder urothelial carcinoma.PRR11 是一种预后生物标志物,与膀胱尿路上皮癌的免疫浸润相关。
Sci Rep. 2023 Feb 4;13(1):2051. doi: 10.1038/s41598-023-29316-2.
6
MTHFD2 is a potential oncogene for its strong association with poor prognosis and high level of immune infiltrates in urothelial carcinomas of bladder.MTHFD2 是一种潜在的致癌基因,因为它与膀胱癌的不良预后和高水平的免疫浸润密切相关。
BMC Cancer. 2022 May 17;22(1):556. doi: 10.1186/s12885-022-09606-0.
7
Comprehensive Analysis Identified ETV7 as a Potential Prognostic Biomarker in Bladder Cancer.全面分析鉴定 ETV7 为膀胱癌潜在的预后生物标志物。
Biomed Res Int. 2021 Dec 9;2021:8530186. doi: 10.1155/2021/8530186. eCollection 2021.
8
Comprehensive Investigation of Genes Associated with Cell Cycle Pathways for Prognosis and Immunotherapy in Bladder Urothelial Carcinoma.全面研究与细胞周期通路相关的基因,以预测和免疫治疗膀胱癌。
J Environ Pathol Toxicol Oncol. 2022;41(3):1-12. doi: 10.1615/JEnvironPatholToxicolOncol.2022041342.
9
RhoJ: an emerging biomarker and target in cancer research and treatment.RhoJ:癌症研究与治疗中的新兴生物标志物和靶标。
Cancer Gene Ther. 2024 Oct;31(10):1454-1464. doi: 10.1038/s41417-024-00792-6. Epub 2024 Jun 10.
10
Predicting Prognosis and Distinguishing Cold and Hot Tumors in Bladder Urothelial Carcinoma Based on Necroptosis-Associated lncRNAs.基于坏死性细胞凋亡相关 lncRNAs 预测膀胱癌预后和鉴别冷肿瘤和热肿瘤。
Front Immunol. 2022 Jul 4;13:916800. doi: 10.3389/fimmu.2022.916800. eCollection 2022.

引用本文的文献

1
Bladder cancer immune-related markers: diagnosis, surveillance, and prognosis.膀胱癌免疫相关标志物:诊断、监测和预后。
Front Immunol. 2024 Nov 4;15:1481296. doi: 10.3389/fimmu.2024.1481296. eCollection 2024.
2
RhoJ: an emerging biomarker and target in cancer research and treatment.RhoJ:癌症研究与治疗中的新兴生物标志物和靶标。
Cancer Gene Ther. 2024 Oct;31(10):1454-1464. doi: 10.1038/s41417-024-00792-6. Epub 2024 Jun 10.

本文引用的文献

1
RHOJ as a novel mechanosensitive modulator of endothelial inflammation.RHOJ 作为一种新型的血管内皮炎症的机械敏感性调节剂。
Biochem Biophys Res Commun. 2023 Aug 30;670:36-46. doi: 10.1016/j.bbrc.2023.05.099. Epub 2023 May 26.
2
RHOJ controls EMT-associated resistance to chemotherapy.RHOJ 控制 EMT 相关的化疗耐药性。
Nature. 2023 Apr;616(7955):168-175. doi: 10.1038/s41586-023-05838-7. Epub 2023 Mar 22.
3
Circulating monocytes associated with anti-PD-1 resistance in human biliary cancer induce T cell paralysis.循环单核细胞与人类胆道癌抗 PD-1 耐药相关,可诱导 T 细胞衰竭。
Cell Rep. 2022 Sep 20;40(12):111384. doi: 10.1016/j.celrep.2022.111384.
4
BCG therapy downregulates HLA-I on malignant cells to subvert antitumor immune responses in bladder cancer.BCG 疗法下调恶性细胞上的 HLA-I 以颠覆膀胱癌中的抗肿瘤免疫反应。
J Clin Invest. 2022 Jun 15;132(12). doi: 10.1172/JCI145666.
5
RhoJ facilitates angiogenesis in glioblastoma via JNK/VEGFR2 mediated activation of PAK and ERK signaling pathways.RhoJ 通过 JNK/VEGFR2 介导的 PAK 和 ERK 信号通路激活促进胶质母细胞瘤血管生成。
Int J Biol Sci. 2022 Jan 1;18(3):942-955. doi: 10.7150/ijbs.65653. eCollection 2022.
6
A high monocyte-to-lymphocyte ratio predicts poor prognosis in patients with radical cystectomy for bladder cancer.高单核细胞与淋巴细胞比值预示着膀胱癌根治性膀胱切除术后患者的预后不良。
Transl Cancer Res. 2020 Sep;9(9):5255-5267. doi: 10.21037/tcr-20-1060.
7
Prevalence of bladder cancer in Costello syndrome: New insights to drive clinical decision-making.考斯特洛综合征中膀胱癌的患病率:新见解推动临床决策。
Clin Genet. 2022 Apr;101(4):454-458. doi: 10.1111/cge.14111. Epub 2022 Feb 17.
8
The prognostic value of MKL1 in predicting breast cancer immune infiltrates and chemosensitivity.MKL1 在预测乳腺癌免疫浸润和化疗敏感性中的预后价值。
Bosn J Basic Med Sci. 2022 Jun 1;22(3):382-394. doi: 10.17305/bjbms.2021.6306.
9
clusterProfiler 4.0: A universal enrichment tool for interpreting omics data.clusterProfiler 4.0:用于解释组学数据的通用富集工具。
Innovation (Camb). 2021 Jul 1;2(3):100141. doi: 10.1016/j.xinn.2021.100141. eCollection 2021 Aug 28.
10
Immunological Hallmarks for Clinical Response to BCG in Bladder Cancer.膀胱癌对卡介苗临床反应的免疫学特征。
Front Immunol. 2021 Jan 29;11:615091. doi: 10.3389/fimmu.2020.615091. eCollection 2020.